0000950170-24-028216.txt : 20240307 0000950170-24-028216.hdr.sgml : 20240307 20240307183539 ACCESSION NUMBER: 0000950170-24-028216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANCHESTER KEITH S CENTRAL INDEX KEY: 0001244828 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 24731829 MAIL ADDRESS: STREET 1: C/O ROIVANT SCIENCES LTD. STREET 2: 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL CITY: LONDON STATE: X0 ZIP: SW1Y 4L ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 ownership.xml 4 X0508 4 2024-03-07 0001635088 Roivant Sciences Ltd. ROIV 0001244828 MANCHESTER KEITH S C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true false false false false Common Shares 2024-03-07 4 J false 11077765 0.00 D 14646796 I Held by QVT Deferred Compensation Holdings Ltd Common Shares 2024-03-07 4 J false 11325233 0.00 D 23105358 I Held by QVT Financial Investment Cayman Ltd. Common Shares 2024-03-07 4 J false 5594064 0.00 D 6837266 I Held by QVT Roiv Hldgs Onshore Ltd. Common Shares 2024-03-07 4 J false 2260661 0.00 D 2763126 I Held by QVT P&E Roiv Hldgs Ltd. Common Shares 1763772 D On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, "QVT Roiv"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration. The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. Includes shares reporting person received as part of the distribution described in (1) above, which is exempted under both Rule 16a-9 and Rule 16a-13 as a change in form of beneficial ownership and (i) an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy (the "Equity Plan"), which vested on September 15, 2023 and (ii) an annual award of restricted stock units with respect to RSU granted pursuant to the Equity Plan, which is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date. /s/ Keith Manchester 2024-03-07